AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.080
-0.210 (-9.17%)
At close: Nov 5, 2026, 4:00 PM EST
2.070
-0.010 (-0.48%)
After-hours: Nov 5, 2026, 4:54 PM EST
AC Immune Market Cap
AC Immune has a market cap or net worth of $206.81 million as of November 5, 2026. It is the 19,769th most valuable company in the world and the 3,458th biggest in the United States. Its market cap has decreased by 35.37% in one year.
Market Cap
206.81M
Enterprise Value
189.03M
1-Year Change
-35.37%
Global Rank
Country Rank
#3,458 United States
Category
ChartMarket Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $206.81M, a decrease of -76.16%. That is a compound annual growth rate of -13.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 233.00M | -26.45% |
| Dec 31, 2025 | 316.80M | 17.51% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
| Sep 23, 2016 | 867.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evommune | 215.58M |
| Keros Therapeutics | 214.73M |
| Palisade Bio | 214.35M |
| Eledon Pharmaceuticals | 213.11M |
| Protalix BioTherapeutics | 210.29M |
| Sol-Gel Technologies | 208.91M |
| Artiva Biotherapeutics | 205.34M |
| Pyxis Oncology | 195.91M |